Nkarta Inc

Stock Chart, Company Information, and Scan Results

$3.23(as of Sep 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Nkarta Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.23
Ticker SymbolNKTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees106
CountyUSA
Market Cap$209.1M
EBIDTA-113.4M
10-Day Moving Average2.80
P/E Ratio0.00
20-Day Moving Average2.62
Forward P/E Ratio0.00
50-Day Moving Average2.61
Earnings per Share-1.66
200-Day Moving Average2.44
Profit Margin0.00%
RSI73.35
Shares Outstanding71.6M
ATR0.18
52-Week High3.72
Volume1,464,033
52-Week Low1.70
Most Recent Support Level2.62
Book Value0.0M
Most Recent Resistance Level2.79
P/B Ratio0.00
Upper Keltner3.03
P/S Ratio0.00
Lower Keltner2.21
Debt-to-Equity Ratio0.00
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Nkarta Inc In Our Stock Scanner

As of Sep 08, 2026
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.